Boston enters vascular sealing market with Sub-Q deal
This article was originally published in Clinica
Boston Scientific has made a series of deals with Sub-Q in order to gain access to the $350 million vascular sealing device market. Boston has gained exclusive worldwide rights to sell the QuickSeal vascular sealing device. It has also made an undisclosed equity investment in Sub-Q and has an exclusive option to buy the private company.